Quick Guide to Oncology & Hematology

Caidya partners with biopharma innovators to bring clarity and confidence to oncology and hematology drug development. With flexible trial design and agile execution, we accelerate timelines while maintaining precision and quality. Our scalable approach and strong global footprint allow us to seamlessly navigate the evolving landscape of oncology and hematology research—supporting both regional and global needs with the speed and adaptability today’s trials demand.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Skip to toolbar